Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Learn the basics of currency risk in international funds and how it can affect diversification and overall performance.
26,930 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
If SpaceX could IPO for a trillion dollars, could Dogecoin catch a similar wave? This article breaks down the odds, t...
Investors often wonder if AMD stock now is the right move. This guide analyzes the catalysts, risks, and practical st...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Palo Alto Networks has seen a meaningful pullback, but a dip can become a doorway for patient investors. This guide b...
AGNC Investment's dividend yield may catch your eye, but a high number isn’t the whole story. This guide breaks down ...
Two bold players are redefining nuclear power. This guide compares Nano Nuclear Energy Nuscale and NuScale Power, unp...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
CME Group confirms a June 8 start for Nasdaq-backed Crypto Index futures. The first market-cap weighted crypto contra...
Investors often chase the high yield offered by Alphabet's convertible preferred stock. This guide breaks down what t...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...